BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kametani Y, Miyamoto A, Tsuda B, Tokuda Y. B Cell Epitope-Based Vaccination Therapy. Antibodies 2015;4:225-39. [DOI: 10.3390/antib4030225] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Yin R, Zhu X, Zeng M, Wu P, Li M, Kwoh CK. A framework for predicting variable-length epitopes of human-adapted viruses using machine learning methods. Brief Bioinform 2022:bbac281. [PMID: 35849093 DOI: 10.1093/bib/bbac281] [Reference Citation Analysis]
2 Yong T, Chang K, Wang Y, Ma C. Active Humoral Response Reverts Tumorigenicity through Disruption of Key Signaling Pathway. Vaccines 2022;10:163. [DOI: 10.3390/vaccines10020163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hoo WPY, Siak PY, Alias NAR, Wong JJ, Tan EW, Song AA, Abdul Rahim R, In LLA. K-ras peptide mimotope induces a humoral immune response against G12V K-ras antigen in BALB/c mice. APJMBB. [DOI: 10.35118/apjmbb.2020.028.3.03] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Singh G, Pritam M, Banerjee M, Singh AK, Singh SP. Designing of precise vaccine construct against visceral leishmaniasis through predicted epitope ensemble: A contemporary approach. Comput Biol Chem 2020;86:107259. [PMID: 32339913 DOI: 10.1016/j.compbiolchem.2020.107259] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
5 Moreno Ayala MA, Gottardo MF, Asad AS, Zuccato C, Nicola A, Seilicovich A, Candolfi M. Immunotherapy for the treatment of breast cancer. Expert Opin Biol Ther 2017;17:797-812. [PMID: 28446053 DOI: 10.1080/14712598.2017.1324566] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
6 Wang JZ, Zhang YH, Guo XH, Zhang HY, Zhang Y. The double-edge role of B cells in mediating antitumor T-cell immunity: Pharmacological strategies for cancer immunotherapy. Int Immunopharmacol 2016;36:73-85. [PMID: 27111515 DOI: 10.1016/j.intimp.2016.04.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]